Bids Are Invited For Price Registration For The Acquisition Of Common Drugs, Aiming To Meet The Needs Of Basic Pharmacies, Emergency Care Unit- Upa And Basic Health Units Of The Municipality Of Peabiru/Pr

Acebrophiline 10Mg/Ml Syrup, Br0448839, Acebrophylline 5Mg/Ml Syrup, Br0448838, Acyclovir, Dosage: 200 Mg - Br0268370, Acetylsalicylic Acid, Dosage: 100 Mg - Br0267502, Ascorbic Acid, Concentration: 200 Mg/Ml, Form Pharmaceutical: Injectable Solution - Br044863, 11/04/2025, Folic Acid, Dosage: 5 Mg - Br0267503, Tranexamic Acid, Dosage: 50 Mg/Ml, Pharmaceutical Form: Injectable Solution - Br0327566, Adenosine, Dosage: 3 Mg/Ml, Indication: Injectable Solution - Br0278281, Albendazole, Dosage: 40 Mg/Ml, Use: Oral Suspension - Br0267507, Dosage: 400 Mg - Br0267506, Sodium Alendronate, Dosage: 70 Mg - Br0269462, Alopurinol, Dosage: 300 Mg - Br0267509, Ambroxol, Composition: Hydrochloride, Salt, Salt Concentration: 3 Mg/Ml, Pharmaceutical Form: Syrup - Br0446264, Concentration: 6 Mg/Ml, Pharmaceutical Form: Syrup - Br0446263, Sulfate Amicacin, Dosage: 250 Mg/Ml, Indication: Injectable Solution - Br0268381, Aminofiline, 24 Mg/Ml, Form Pharmaceutical: Injectable Solution - Br0292402, Amiodarone, Dosage: 200 Mg - Br0267510, Dosage: 50Mg/Ml, Indication: Injectable - Br0271710, Amoxicillin 500 Mg Cpr - Br 0271089, Amoxicillin, Concentration: 50 Mg/Ml, Presentation: Powder For Oral Suspension - Br0271111, Active Ingredient: Associated With Potassium Clavulanate, Concentration: 50 Mg/Ml + 12, 5 Mg/Ml, Pharmaceutical Form: Oral Suspension - Br0448841, Concentration: 500Mg + 125Mg - Br0271217, Anlodipino Beesylate, Dosage: 5 Mg Br0272434, Atenolol, Dosage: 50 Mg - Br0267517, Atropine Sulfate, Dosage: 0, 25 Mg/Ml, Use: Injectable Solution - Br0268214, 50 Mg/Ml, Use: Injectable Solution - Br0277934, Azithromycin, Presentation: Oral Suspension - Br0268949, 500 Mg - Br0267140, Benzilpenyicillin, Presentation: Benzatin, Dosage: 600.000Ui, Use: Injectable - Br0270613, Dosage: 1.200.000Ui, Use: Injectable - Br0270612, Benzoilmetrinidazole, Concentration: 40 Mg/Ml, Pharmaceutical Form: Oral Suspension - Br0394856, Bicarbonate Sodium, Concentration: 8, 40%, Pharmaceutical Form: Injectable Solution, Additional Characteristic: In Closed System - Br0394088, Dosage: 8, 4%, Use: Injectable Solution - Br0268222, Bromopride 4 Mg/ Ml Oral Solution, Br0269956, Bromopride, Dosage: 5 Mg/ Ml, Presentation: Injectable - Br0269958, Budesonide, Presentation: Nasal Aerosol, Concentration: 64Mcg/Dose, Additional Characteristics: Vial With Dosificator Valve - Bottle With 120 Doses- Br0266707, Concentration: 32Mcg/Dose, Additional Characteristics: Bottle With Dossifier - Bottle 120, 00 Doses - Br0266706, Carbonate Calcium, Composition: 1500Mg + 400 Iu, Pharmaceutical Form: Masticable Tablet - Br0407241, Composition: Associated With Vitamin D3, Concentration: 600 Mg + 400 Iu - Br0396076, Activated Charcoal: Black, Odor, Molecular Weight: 12, 01 G/Mol, Chemical Formula: C, Minimum Purity Of 90%, Additional Feature: Reagent P.A., Chemical Reference Number: Cas 7440-44-0 - Br0348073, Carvedilol 12, 5 Mg - Br0267564, Carvedilol, Dosage: 25 Mg - Br0267567, Dosage: 3, 125 Mg - Br0267566, Dosage: 6, 25 Mg - Br0267565, Cephalexin, Pharmaceutical Form: Powder For Oral Suspension - Vial 60, 00 Ml - Br0331555, Dosage: 500 Mg - Br0267625, Sodium Ceftriaxone, Concentration: 1 G, Pharmaceutical Form: Powder For Injectable Solution + Diluent - Br0450890 Injectable + Lidocaine - Br0450891, Ketoprofen, Concentration: 100 Mg, Pharmaceutical Form: Injectable Liophile Powder - Br0448844, Concentration: 50 Mg/ Ml, Pharmaceutical Form: Injectable Solution - Br0448845, Cyclobenzaprine, Dosage: 10 Mg